Park Avenue Securities’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
2,470
+206
| +9% | +$111K | 0.01% | 671 |
|
|
2025
Q1 | $951K | Buy |
2,264
+351
| +18% | +$147K | 0.01% | 640 |
|
|
2024
Q4 | $791K | Sell |
1,913
-1,184
| -38% | -$490K | 0.01% | 866 |
|
|
2024
Q3 | $1.57M | Sell |
3,097
-510
| -14% | -$258K | 0.02% | 500 |
|
|
2024
Q2 | $1.76M | Sell |
3,607
-43
| -1% | -$20.9K | 0.02% | 454 |
|
|
2024
Q1 | $1.97M | Sell |
3,650
-245
| -6% | -$132K | 0.03% | 417 |
|
|
2023
Q4 | $2.16M | Sell |
3,895
-288
| -7% | -$160K | 0.03% | 360 |
|
|
2023
Q3 | $1.83M | Buy |
+4,183
| New | +$1.83M | 0.03% | 358 |
|
|
2023
Q1 | – | Sell |
-4,304
| Closed | -$1.76M | – | 913 |
|
|
2022
Q4 | $1.76M | Sell |
4,304
-199
| -4% | -$81.2K | 0.03% | 340 |
|
|
2022
Q3 | $1.47M | Buy |
4,503
+389
| +9% | +$127K | 0.03% | 339 |
|
|
2022
Q2 | $1.44M | Buy |
4,114
+472
| +13% | +$166K | 0.03% | 345 |
|
|
2022
Q1 | $1.99M | Buy |
3,642
+384
| +12% | +$210K | 0.04% | 282 |
|
|
2021
Q4 | $2.15M | Buy |
3,258
+133
| +4% | +$87.6K | 0.04% | 269 |
|
|
2021
Q3 | $1.94M | Sell |
3,125
-43
| -1% | -$26.7K | 0.04% | 246 |
|
|
2021
Q2 | $2M | Sell |
3,168
-287
| -8% | -$181K | 0.04% | 228 |
|
|
2021
Q1 | $1.69M | Buy |
3,455
+5
| +0.1% | +$2.45K | 0.04% | 229 |
|
|
2020
Q4 | $1.73M | Buy |
3,450
+733
| +27% | +$367K | 0.05% | 180 |
|
|
2020
Q3 | $1.07M | Buy |
2,717
+858
| +46% | +$337K | 0.04% | 229 |
|
|
2020
Q2 | $614K | Buy |
+1,859
| New | +$614K | 0.02% | 302 |
|